Search
Displaying 551–560 of 851 results for “vision connection”
-
How an FDA-Approved Retinal Prosthesis Came To Be
Research NewsThe Argus II Retinal Prosthesis System was recently granted market approval by the U.S. Food and Drug Administration (FDA), which marks a significant milestone in the development of a therapy that has spanned more than 20 years.
-
Safely Harnessing the Power of Stem Cells
Research NewsIn the not-too-distant future, researchers will be able to turn stem cells into new photoreceptors for people who have lost vision to a retinal disease. But they must also carefully harness their power to ensure positive consequences.
-
Could Combining Future Treatments Be an Option?
Research NewsHow therapies will likely be used synergistically in the future.
-
Sepul Bio’s LCA10 RNA Therapy Moves into Phase 3 Clinical Trial
Research NewsThe emerging therapy improved vision for some participants in an earlier clinical trial.
-
Letter to House Energy & Commerce Committee regarding H.R.1262, the Give Kids a Chance Act.
Advocacy Research NewsOn behalf of the Foundation Fighting Blindness and the millions of Americans impacted by inherited retinal diseases (IRDs), we urge you to advance H.R.1262, the Give Kids a Chance Act, and reauthorize the Rare Pediatric Disease Priority Review Voucher (PRV) Program.
-
Beacon Stories
Maverick, a determined and adventurous 11-year-old, was diagnosed with X-linked retinoschisis (XLRS) at age six, which led his family to find support and resources through the Foundation Fighting Blindness. Since his diagnosis, Mav continues to pursue his passions in sports and outdoor activities, inspiring his family with his resilience and positive attitude.
-
From its legendary cowboy culture to world-class art, lush outdoor escapes, and a vibrant food scene, Fort Worth offers something for everyone. Whether you’re exploring the iconic Stockyards, strolling through the Cultural District, or enjoying the city’s lively neighborhoods, you’ll find plenty of ways to make the most of your visit during United in Vision 2026.
-
Opus Genetics Receives FDA Clearance to Launch Clinical Trial for Best1 Gene Therapy
Research NewsThe Foundation funded earlier, proof-of-concept studies for the Best1 gene therapy and later launched Opus to develop several IRD gene therapies.
-
jCyte Launches New Phase 2 Clinical Trial for its Cell-Based RP Therapy
Research NewsThe trial is evaluating a cell dose that is 50 percent higher than the highest dose used in a previous Phase 2b trial.
-
About Page
The Foundation Fighting Blindness Brand Ambassador Program empowers passionate individuals affected by blinding diseases to share their stories, raise awareness, and inspire action in the fight against vision loss. Together, we’re amplifying voices and accelerating our path to treatments and cures.
